Subject
Now showing items 1-3 of 3
-
Molecular characterization of HIV type 1 among HIV-infected respondents in a cohort being prepared for HIV phase III vaccine clinical trials, Western Kenya
(2011)Kenya is one of the sub-Saharan African countries affected by HIV-1 infection and AIDS. We investigated HIV-1 genetic diversity in 130 individuals from Busia, Bungoma, and Kakamega in western Kenya as part of an HIV-1 ... -
Thrombocytopoenia as marker for HIV exposure in the neonate
(2001)Thrombocytopoenia is a well-described marker of human immunedeficiency virus type 1 (HIV) infection of children. After documenting thrombocytopoenia in a HIV-exposed neonate, who was subsequently shown not to be infected, ... -
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: An indication of viral fitness?
(2003)Naturally occurring polymorphisms in the protease of human immunodeficiency virus type 1 (HIV-1) subtype C would be expected to lead to adaptive (compensatory) changes in protease cleavage sites. To test this hypothesis, ...